Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker KRYS
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Suma Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $9.3M | 10b5-1 | Sep 4, 2026 | Form 4 ↗ same day · 25,000 shares | Form 144 ↗ |
| Sep 4, 2026 | Krish Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $9.3M | 10b5-1 | Sep 4, 2026 | Form 4 ↗ same day · 25,000 shares | Form 144 ↗ |
| Aug 14, 2026 | Dino A. Rossi Director | KRYS Krystal Biotech, Inc. | 25,000 | $8.3M | — | Aug 14, 2026 | Form 4 ↗ same day · 25,000 shares | Form 144 ↗ |
| Jun 25, 2026 | Thomas John Charles Officer | KRYS Krystal Biotech, Inc. | 1,000 | $347.3K | 10b5-1 | Jun 25, 2026 | Form 4 ↗ 1 day later · 1,000 shares | Form 144 ↗ |
| Jun 4, 2026 | Suma Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $7.5M | 10b5-1 | Jun 4, 2026 | Form 4 ↗ 1 day later · 25,000 shares | Form 144 ↗ |
| Jun 4, 2026 | Krish Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $7.5M | 10b5-1 | Jun 4, 2026 | Form 4 ↗ 1 day later · 25,000 shares | Form 144 ↗ |
| May 26, 2026 | Thomas John Charles Officer | KRYS Krystal Biotech, Inc. | 642 | $193.9K | 10b5-1 | May 26, 2026 | Form 4 ↗ 1 day later · 642 shares | Form 144 ↗ |
| Mar 4, 2026 | Suma Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $6.6M | 10b5-1 | Mar 4, 2026 | Form 4 ↗ 2 days later · 25,000 shares | Form 144 ↗ |
| Mar 4, 2026 | Krish Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $6.6M | 10b5-1 | Mar 4, 2026 | Form 4 ↗ 2 days later · 25,000 shares | Form 144 ↗ |
| Mar 2, 2026 | Kathryn Romano Officer | KRYS Krystal Biotech, Inc. | 750 | $200.7K | 10b5-1 | Mar 2, 2026 | Form 4 ↗ 1 day later · 750 shares | Form 144 ↗ |
| Feb 27, 2026 | Daniel S Janney Director | KRYS Krystal Biotech, Inc. | 11,803 | $3.3M | 10b5-1 | Feb 27, 2026 | Form 4 ↗ 4 days later · 11,803 shares | Form 144 ↗ |
| Feb 26, 2026 | Daniel S Janney Director | KRYS Krystal Biotech, Inc. | 7,741 | $2.1M | 10b5-1 | Feb 26, 2026 | Form 4 ↗ same day · 60,161 shares | Form 144 ↗ |
| Feb 25, 2026 | Daniel S Janney Director | KRYS Krystal Biotech, Inc. | 700 | $192.5K | 10b5-1 | Feb 25, 2026 | Form 4 ↗ 1 day later · 60,161 shares | Form 144 ↗ |
| Feb 24, 2026 | Daniel Janney Director | KRYS Krystal Biotech, Inc. | 37,895 | $10.1M | 10b5-1 | Feb 24, 2026 | Form 4 ↗ 2 days later · 60,161 shares | Form 144 ↗ |
| Feb 24, 2026 | Daniel S Janney Director | KRYS Krystal Biotech, Inc. | 13,825 | $3.7M | 10b5-1 | Feb 24, 2026 | Form 4 ↗ 2 days later · 60,161 shares | Form 144 ↗ |
| Feb 19, 2026 | Dino A. Rossi Director | KRYS Krystal Biotech, Inc. | 18,950 | $5.0M | — | Feb 19, 2026 | Form 4 ↗ 4 days later · 18,950 shares | Form 144 ↗ |
| Feb 9, 2026 | Kathryn Romano Officer | KRYS Krystal Biotech, Inc. | 12,500 | $3.5M | 10b5-1 | Feb 9, 2026 | Form 4 ↗ 2 days later · 12,500 shares | Form 144 ↗ |
| Dec 4, 2025 | Krish Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $5.4M | 10b5-1 | Dec 4, 2025 | Form 4 ↗ 1 day later · 50,000 shares | Form 144 ↗ |
| Dec 4, 2025 | Suma Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $5.4M | 10b5-1 | Dec 4, 2025 | Form 4 ↗ 1 day later · 50,000 shares | Form 144 ↗ |
| Jul 9, 2025 | Suma Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $3.6M | 10b5-1 | Jul 9, 2025 | Form 4 ↗ 2 days later · 14,127 shares | Form 144 ↗ |
| Jul 9, 2025 | Krish Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $3.6M | 10b5-1 | Jul 9, 2025 | Form 4 ↗ 2 days later · 14,127 shares | Form 144 ↗ |
| Mar 13, 2025 | Suma Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $4.5M | 10b5-1 | Mar 13, 2025 | Form 4 ↗ same day · 50,000 shares | Form 144 ↗ |
| Mar 13, 2025 | Krish S Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $4.5M | 10b5-1 | Mar 13, 2025 | Form 4 ↗ same day · 50,000 shares | Form 144 ↗ |
| Feb 27, 2025 | Kathryn Romano Officer | KRYS Krystal Biotech, Inc. | 750 | $131.4K | 10b5-1 | Feb 27, 2025 | Form 4 ↗ 1 day later · 750 shares | Form 144 ↗ |
| Dec 13, 2024 | Krish S Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $4.3M | 10b5-1 | Dec 13, 2024 | Form 4 ↗ same day · 50,000 shares | Form 144 ↗ |
| Dec 13, 2024 | Suma Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $4.3M | 10b5-1 | Dec 13, 2024 | Form 4 ↗ same day · 50,000 shares | Form 144 ↗ |
| Sep 12, 2024 | Suma Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $5.0M | 10b5-1 | Sep 12, 2024 | — | Form 144 ↗ |
| Sep 12, 2024 | Krish Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $5.0M | 10b5-1 | Sep 12, 2024 | — | Form 144 ↗ |
| Jun 11, 2024 | Krish Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $4.4M | 10b5-1 | Jun 11, 2024 | — | Form 144 ↗ |
| Jun 11, 2024 | Suma Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $4.4M | 10b5-1 | Jun 11, 2024 | — | Form 144 ↗ |
| May 20, 2024 | Julian S. Gangolli Director | KRYS Krystal Biotech, Inc. | 20,000 | $3.3M | — | May 20, 2024 | — | Form 144 ↗ |
| Mar 11, 2024 | Suma Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $4.3M | 10b5-1 | Mar 11, 2024 | — | Form 144 ↗ |
| Mar 11, 2024 | Krish Krishnan Director, Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $4.3M | 10b5-1 | Mar 11, 2024 | — | Form 144 ↗ |
| Feb 28, 2024 | Kathryn Romano Officer | KRYS Krystal Biotech, Inc. | 12,500 | $2.1M | 10b5-1 | Feb 28, 2024 | — | Form 144 ↗ |
| Feb 26, 2024 | Kathryn Romano Officer | KRYS Krystal Biotech, Inc. | 8,087 | $1.1M | 10b5-1 | Feb 26, 2024 | — | Form 144 ↗ |
| Jan 22, 2024 | Kathryn Romano Officer | KRYS Krystal Biotech, Inc. | 2,500 | $325.0K | 10b5-1 | Jan 22, 2024 | — | Form 144 ↗ |
| Dec 11, 2023 | Suma Krishnan Officer | KRYS Krystal Biotech, Inc. | 25,000 | $2.7M | 10b5-1 | Dec 11, 2023 | — | Form 144 ↗ |
| Dec 11, 2023 | Krish Krishnan Officer | KRYS Krystal Biotech, Inc. | 25,000 | $2.7M | 10b5-1 | Dec 11, 2023 | — | Form 144 ↗ |
| Oct 2, 2023 | Andrew C. Orth Former Officer | KRYS Krystal Biotech, Inc. | 3,164 | $362.3K | — | Oct 2, 2023 | — | Form 144 ↗ |
| Sep 11, 2023 | Krish Krishnan Officer | KRYS Krystal Biotech, Inc. | 25,000 | $3.1M | 10b5-1 | Sep 11, 2023 | — | Form 144 ↗ |
| Sep 11, 2023 | Suma Krishnan Officer | KRYS Krystal Biotech, Inc. | 25,000 | $3.1M | 10b5-1 | Sep 11, 2023 | — | Form 144 ↗ |
| Aug 21, 2023 | Andrew C. Orth Former Officer | KRYS Krystal Biotech, Inc. | 16,728 | $2.1M | — | Aug 21, 2023 | — | Form 144 ↗ |
| Aug 16, 2023 | Andrew C. Orth Former Chief Commercial Officer | KRYS Krystal Biotech, Inc. | 67,551 | $8.2M | — | Aug 16, 2023 | — | Form 144 ↗ |
| Aug 15, 2023 | Andrew C. Orth Former EVP & CCO | KRYS Krystal Biotech, Inc. | 8,048 | $981.9K | — | Aug 15, 2023 | — | Form 144 ↗ |
| Aug 11, 2023 | Andrew C. Orth Former EVP & CCO | KRYS Krystal Biotech, Inc. | 1,503 | $183.4K | — | Aug 11, 2023 | — | Form 144 ↗ |
| Aug 10, 2023 | Andrew C. Orth Officer | KRYS Krystal Biotech, Inc. | 5,606 | $685.2K | — | Aug 10, 2023 | — | Form 144 ↗ |
| Jun 9, 2023 | Andrew Orth Officer | KRYS Krystal Biotech, Inc. | 12,500 | $1.6M | 10b5-1 | Jun 9, 2023 | — | Form 144 ↗ |
| Jun 8, 2023 | Daniel Janney Director | KRYS Krystal Biotech, Inc. | 50,000 | $6.4M | — | Jun 8, 2023 | — | Form 144 ↗ |
| May 31, 2023 | Krish Krishnan Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $2.9M | — | May 31, 2023 | — | Form 144 ↗ |
| May 31, 2023 | Suma Krishnan Officer, 10% Stockholder | KRYS Krystal Biotech, Inc. | 25,000 | $2.9M | — | May 31, 2023 | — | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 8:50 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances